Editor
Ebrahim Mostafavi
Associate Editor-in-Chief at Dove Medical Press, Stanford University School of Medicine, United States
About
As published by the journal they serve.
"Dr. Ebrahim Mostafavi is currently at Stanford Cardiovascular Institute, School of Medicine. His research interests revolve around the use of cardiac iPS cells to design and develop in vitro models for cardiovascular disease modeling and drug screening. Dr. Mostafavi received his Ph.D. in Chemical Engineering (with a focus on Biomedical Engineering, Biomaterials, Tissue Engineering and Regenerative Medicine) from Northeastern University, Boston, MA. During his doctoral training, he received several prestigious awards. Dr. Mostafavi serves as an Associate Editor-in-Chief for the International Journal of Nanomedicine (IF= 5.115, 5-year IF= 5.166, Q1 Bioengineering). He also serves as a verified peer-reviewer (50+ documents) for over 18 different high-impact journals from prestigious publishers such as Nature, Elsevier, Springer Nature, Wiley, Taylor & Francis, Dove Press, PLOS, IOPscience, etc. His scholarly work consists of > 40 publications with an H-index of 17 (i10-index= 22) on Google Scholar Profile. He also contributed to 7 book chapters and was selected as the editor of a few books, including “Advances in Cardiovascular Biomaterials” and "Emerging Nanomaterials to Combat Antimicrobial Resistance."
Research interests
Qualifications
PhD
Journals they serve
The seats these journals name them in.
- Journal of Next Generation Sequencing & ApplicationsEditor
- Journal of Next Generation Sequencing & ApplicationsEditorial Board Member
Articles we hold
Articles in the journals they serve whose byline carries this name.
No article in our collection carries this name on its byline. Not every article names its authors in a way that can be matched, so this is not a list of everything they have written.
This page holds what the journals publish about this profile: no contact details, and nothing gathered from anywhere else. Ask us to correct or remove this profile.